Adverum Biotechnologies Inc Strategic Asset Allocation Index
Adverum Biotechnologies Inc strategic asset allocation index. Adverum Biotechnologies Inc (ADVM) has a Strategic Asset Allocation Index of 66.5% as of September 2023. Strategic assets (PP&E of $68.25 Million plus long-term investments of $-) total $68.25 Million, measured against net assets of $102.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ADVM equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Adverum Biotechnologies Inc (2014–2022)
Strategic asset allocation index of Adverum Biotechnologies Inc from 2014 to 2022. This chart shows how Adverum Biotechnologies Inc's Strategic Asset Allocation Index has evolved across 9 annual periods from 2014 to 2022. As of September 2023, the index stands at 66.5%, representing strategic assets of $68.25 Million against net assets of $102.71 Million USD. Check Adverum Biotechnologies Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Adverum Biotechnologies Inc Strategic Asset Allocation Index by Year (2014–2022)
Adverum Biotechnologies Inc strategic asset allocation index by year from 2014 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Adverum Biotechnologies Inc from 2014 to 2022, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Adverum Biotechnologies Inc (ADVM) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.7% | $113.86 Million | $113.86 Million | $- | $181.52 Million | ▲ +52.3 pp |
| 2021 | 10.5% | $33.06 Million | $33.06 Million | $- | $316.19 Million | ▲ +4.1 pp |
| 2020 | 6.4% | $27.73 Million | $27.73 Million | $- | $434.35 Million | ▼ -7.8 pp |
| 2019 | 14.2% | $24.88 Million | $24.88 Million | $- | $174.96 Million | ▲ +12.4 pp |
| 2018 | 1.8% | $3.59 Million | $3.59 Million | $- | $201.17 Million | ▲ +0.1 pp |
| 2017 | 1.6% | $3.02 Million | $3.02 Million | $- | $184.03 Million | ▼ -0.3 pp |
| 2016 | 1.9% | $4.17 Million | $4.17 Million | $- | $215.60 Million | ▲ +0.7 pp |
| 2015 | 1.3% | $3.19 Million | $3.19 Million | $- | $252.59 Million | ▲ +0.5 pp |
| 2014 | 0.7% | $1.08 Million | $1.08 Million | $- | $149.48 Million | — |